Literature DB >> 30905357

Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget's Diseases.

Guohong Zhang1, Songxia Zhou1, Weixiang Zhong2, Liangli Hong3, Yuanyuan Wang4, Shanming Lu5, Jiankai Pan6, Yuansheng Huang7, Mingwan Su7, Richard Crawford7, Youwen Zhou8, Ruiqin Mai9.   

Abstract

Paget's disease (PD) is an intraepidermal adenocarcinoma of the skin at the breast (mammary PD) or urogenital locations (extramammary PD [EMPD]). At present, there is lack of clarity on PD's pathogenesis, the relationship between its subtypes, and its lineage link with the underlying invasive carcinomas. Here we describe that mammary PD and EMPD have similar mutational profiles, with the most frequent recurrent mutations occurring in the chromatin remodeling genes, such as KMT2C (MLL3, 39%) and ARID2 (22%), with additional recurrent somatic mutations detected in genes previously not known to be mutated in cancers, such as CDCC168 (34%), FSIP2 (29%), CASP8AP2 (29%), and BIRC6 (24%). In paired mammary PD and underlying breast carcinoma samples, distinct gene mutations were detected, indicating that they represent independent oncogenic events. Finally, multistage EMPD tissue sequencing revealed KMT2C gene occurring early in EMPD oncogenesis, and that multifocal EMPD samples share the same early gene mutations, suggesting clonal origin of multifocal EMPD. Our results reveal similar genomic landscapes between mammary PD and EMPD, including early aberrations in chromatin remodeling genes. In addition, mammary PD and underlying breast ductal carcinomas represent independent oncogenic events. These findings provide approaches for developing diagnostic tools and therapeutic interventions for PD.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 30905357     DOI: 10.1016/j.jid.2018.08.030

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Correlation analysis between androgen receptor and the clinicopathological features and prognosis of mammary Paget's disease.

Authors:  Yang Wu; Shanshan Sun; Yuanxi Huang; Min Xiao; Xuhai Zhao; Xiangshi Lu; Bingshu Xia; Kun Qiao; Shiyuan Zhang; Qiqi Wu; Jing Xiong; Shaoqiang Cheng; Yanni Song
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-02       Impact factor: 4.553

2.  Dysregulated Immune and Metabolic Microenvironment Is Associated with the Post-Operative Relapse in Stage I Non-Small Cell Lung Cancer.

Authors:  Shirong Zhang; Xiao Xiao; Xiuli Zhu; Xueqin Chen; Xiaochen Zhang; Jingjing Xiang; Rujun Xu; Zhuo Shao; Jing Bai; Yanping Xun; Yanping Jiang; Zhengzheng Chen; Xuefeng Xia; Hong Jiang; Shenglin Ma
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

Review 3.  Current Management and Treatment of Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Takamichi Ito
Journal:  Curr Treat Options Oncol       Date:  2022-04-04

4.  Establishment and characterization of breast cancer organoids from a patient with mammary Paget's disease.

Authors:  Bo Pan; Dongyi Zhao; Yaqian Liu; Na Li; Chen Song; Ning Li; Xuelu Li; Man Li; Zuowei Zhao
Journal:  Cancer Cell Int       Date:  2020-08-03       Impact factor: 5.722

5.  CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Yumiko Kaku-Ito; Yoshinao Oda; Takamichi Ito
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

6.  Clinicopathological Characteristics and Survival Outcomes of Mammary Paget's Disease: A Retrospective Study Based on a Chinese Population.

Authors:  Bo-Yue Han; Xiao-Li Xu; Xiu-Zhi Zhu; Xiang-Chen Han; Xin Hu; Hong Ling
Journal:  Cancer Manag Res       Date:  2022-01-18       Impact factor: 3.989

7.  Transcriptome sequencing reveals a lncRNA-mRNA interaction network in extramammary Paget's disease.

Authors:  Da-Chao Zheng; Yan-Ting Shen; Zi-Wei Wei; Xiang Wan; Min-Kai Xie; Hai-Jun Yao; Zhong Wang
Journal:  BMC Med Genomics       Date:  2021-12-11       Impact factor: 3.063

8.  Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma.

Authors:  Haoxuan Ying; Anqi Lin; Junyi Liang; Jian Zhang; Peng Luo
Journal:  Front Mol Biosci       Date:  2021-05-24

9.  Frequent FOXA1-Activating Mutations in Extramammary Paget's Disease.

Authors:  Takuya Takeichi; Yusuke Okuno; Takaaki Matsumoto; Nobuyuki Tsunoda; Kyogo Suzuki; Kana Tanahashi; Michihiro Kono; Toyone Kikumori; Yoshinao Muro; Masashi Akiyama
Journal:  Cancers (Basel)       Date:  2020-03-29       Impact factor: 6.639

10.  Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).

Authors:  Maki Ishii; Ikuko Hirai; Keiji Tanese; Takayuki Fusumae; Yoshio Nakamura; Keitaro Fukuda; Hiroshi Uchi; Kenji Kabashima; Atsushi Otsuka; Kenji Yokota; Naoya Yamazaki; Kenjiro Namikawa; Taku Fujimura; Tatsuya Takenouchi; Yuki Yamamoto; Mana Nishiguchi; Yasunori Sato; Masayuki Amagai; Takeru Funakoshi
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.